心脏膜疾病在心脏粉症患者的心脏粉症
Alberto Aimo1,2, Lara Camerini3, Iacopo Fabiani4
1Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56127, Pisa, Italy. albertoaimo@libero.it.
Heart failure reviews
|September 22, 2023
概括
心脏粉症 (CA) 可以影响心脏门,导致大动脉狭窄,友节回和三回. 本综述探讨了它们对CA患者的影响,诊断和治疗.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 氨基粉症研究研究
背景情况:
- 心脏粉症 (CA) 涉及错误折叠的蛋白质沉积在心脏中.
- 粉样蛋白透会损害心脏门的结构和功能.
- 膜疾病显著影响CA患者的预后和生活质量.
研究的目的:
- 审查CA中膜疾病的流行病学,机制和临床影响.
- 总结一下大动脉狭窄症 (AS) 的诊断特征和治疗策略,大动脉狭窄症 (AS), mitra regurgitation (MR) 和三 regurgitation (TR) 在CA.
- 要突出诊断同时存在的CA和AS的挑战.
主要方法:
- 对流行病学数据的文献综述.
- 疾病机制和病理生理学的分析.
- 合成心声回声检测结果和临床结果.
- 对CA中膜功能障碍的当前治疗选择的评估.
主要成果:
- 大动脉狭窄 (AS),额头吐 (MR) 和三角吐 (TR) 是CA的常见膜表现.
- CA和AS共享风险因素和诊断挑战,结合条件导致更糟糕的结果.
- 过导管大动脉置换对AS的CA患者来说是有希望的.
- 在CA中关于MR和TR的数据有限,主要来自病例报告.
结论:
- 膜心脏病是心脏粉症的一个关键并发症.
- 早期诊断和AS,MR和TR的适当管理对于改善CA患者的治疗结果至关重要.
- 需要进一步的研究,以阐明在CA中MR和TR的全谱和最佳治疗.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:23Rheumatic Heart Disease I: Introduction
14
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
01:25Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12